Lineage Cell Therapeutics (LCTX) Receivables (2011 - 2026)
Lineage Cell Therapeutics (LCTX) recorded Receivables of $956,000 in Q2 2026, up 273.4% from $256,000 a year earlier but down 31.3% from the prior quarter.
Powered by 
Analysis
Lineage Cell Therapeutics (LCTX) Receivables (2011 - 2026) Analysis & Trends
At the end of FY2025, Lineage Cell Therapeutics reported Receivables of $1.56 million, up 144.8% from FY2024.
- Annual Receivables has a five-year compound annual growth rate of 45.2% (FY2020 to FY2025).
- Across earlier years, Receivables came in at $638,000 in FY2024 (-14.4%), $745,000 in FY2023 (+148.3%), $300,000 in FY2022 (-99.4%) and $50.84 million in FY2021.
- Quarterly Receivables has ranged from $77,000 in Q1 2024 to $50.84 million in Q4 2021 over the past five years.
- On a year-over-year basis, Receivables has increased for six consecutive quarters, with growth averaging 150.4% over the last eight quarters.
- Peak year-over-year performance for Receivables in the last five years was growth of 668.8% in Q3 2021, against a decline of 99.4% in Q4 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $1.39 million (Q1 2026), $1.56 million (Q4 2025) and $676,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 19.05 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 13.82 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 12.56 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 9.64 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 15.68 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 10.23 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 5.06 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 12.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 2.13 Bn |
| 10 | Lineage Cell Therapeutics | 245.32 Mn | 43.73 Mn | - | 956,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 956,000.00 |
| Mar 31, 2026 | 1.39 Mn |
| Dec 31, 2025 | 1.56 Mn |
| Sep 30, 2025 | 676,000.00 |
| Jun 30, 2025 | 256,000.00 |
| Mar 31, 2025 | 213,000.00 |
| Dec 31, 2024 | 638,000.00 |
| Sep 30, 2024 | 405,000.00 |
| Jun 30, 2024 | 235,000.00 |
| Mar 31, 2024 | 77,000.00 |
| Dec 31, 2023 | 745,000.00 |
| Sep 30, 2023 | 432,000.00 |
| Jun 30, 2023 | 443,000.00 |
| Mar 31, 2023 | 173,000.00 |
| Dec 31, 2022 | 300,000.00 |
| Sep 30, 2022 | 435,000.00 |
| Jun 30, 2022 | 732,000.00 |
| Mar 31, 2022 | 323,000.00 |
| Dec 31, 2021 | 50.84 Mn |
| Sep 30, 2021 | 2.12 Mn |
API Access
Lineage Cell Therapeutics Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=LCTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "LCTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=LCTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();